Lista de obras -

A Phase I study of CHS 828 in patients with solid tumor malignancy

artículo científico publicado en 2002

A catalyst for change: the European cancer Patient's Bill of Rights

artículo científico publicado en 2014

A retrospective study of SBRT of metastases in patients with primary sarcoma

artículo científico publicado en 2012

A simple method for assigning genomic grade to individual breast tumours

artículo científico publicado en 2011

Adjuvant chemotherapy for breast cancer--"one fits all"?

artículo científico publicado en 2005

Age-specific trends of survival in metastatic breast cancer: 26 years longitudinal data from a population-based cancer registry in Stockholm, Sweden

artículo científico publicado en 2011

An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival

artículo científico publicado en 2005

An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer

artículo científico publicado en 2008

An iron regulatory gene signature predicts outcome in breast cancer.

artículo científico publicado en 2011

Best use of adjuvant systemic therapies II, chemotherapy aspects: dose of chemotherapy-cytotoxicity, duration and responsiveness

artículo científico publicado en 2003

Breast cancer associated with primary hyperparathyroidism: a nested case control study

artículo científico publicado en 2011

Breast tumour stroma is a prognostic indicator and target for therapy

artículo científico publicado en 2009

Characterisation of the G1/S cell cycle checkpoint defect in lung carcinoma cells with different intrinsic radiosensitivities

artículo científico publicado el 1 de septiembre de 1997

Clinical instability of breast cancer markers is reflected in long-term in vitro estrogen deprivation studies

artículo científico publicado en 2013

Comprehensive long-span paired-end-tag mapping reveals characteristic patterns of structural variations in epithelial cancer genomes

artículo científico publicado en 2011

Contrasting breast cancer molecular subtypes across serial tumor progression stages: biological and prognostic implications

artículo científico publicado en 2015

Correlation test to assess low-level processing of high-density oligonucleotide microarray data

artículo científico publicado en 2005

Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade

artículo científico publicado en 2007

Dose intense, dose dense and tailored dose adjuvant chemotherapy for early breast cancer: an evolution of concepts

artículo científico publicado en 2017

ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016

artículo científico publicado en 2016

Erythropoietin therapy and cancer related anaemia: updated Swedish recommendations

artículo científico publicado en 2007

Expression of Nestin associates with BRCA1 mutations, a basal-like phenotype and aggressive breast cancer

artículo científico publicado en 2017

Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts

artículo científico publicado en 2005

Great risk of future problems for Swedish cancer care

artículo científico publicado el 6 de octubre de 2010

Growth-inhibitory and tumor- suppressive functions of p53 depend on its repression of CD44 expression

artículo científico publicado en 2008

High expression of stromal PDGFRβ is associated with reduced benefit of tamoxifen in breast cancer

scientific article published on 14 September 2016

High-dose chemotherapy with autologous stem-cell support as adjuvant therapy in breast cancer: overview of 15 randomized trials.

artículo científico publicado en 2011

Hormone-replacement therapy influences gene expression profiles and is associated with breast-cancer prognosis: a cohort study

artículo científico publicado en 2006

How to treat male breast cancer

artículo científico publicado en 2007

Immunohistochemistry compared to cytosol assays for determination of estrogen receptor and prediction of the long-term effect of adjuvant tamoxifen ⬇️

artículo científico publicado el 19 de octubre de 2010

Inactivation of FBXW7/hCDC4-β expression by promoter hypermethylation is associated with favorable prognosis in primary breast cancer

artículo científico publicado en 2010

Increased radioresistance of an in vitro transformed human small cell lung cancer cell line ⬇️

artículo científico publicado el 1 de junio de 1995

Inhibitory effects of estrogen receptor beta on specific hormone-responsive gene expression and association with disease outcome in primary breast cancer

artículo científico publicado en 2007

Interactions between immunity, proliferation and molecular subtype in breast cancer prognosis

scientific article published on 29 April 2013

Interventional Techniques for Bone and Musculoskeletal Soft Tissue Tumors: Current Practices and Future Directions - Part I. Ablation

artículo científico publicado en 2020

Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients

artículo científico publicado en 2006

Long-term outcome in young women with breast cancer: a population-based study

artículo científico publicado en 2016

MICADo - Looking for Mutations in Targeted PacBio Cancer Data: An Alignment-Free Method

artículo científico publicado en 2016

Multidisciplinary meeting on male breast cancer: summary and research recommendations

artículo científico publicado en 2010

Phase III Randomized Study Comparing Docetaxel Plus Trastuzumab With Vinorelbine Plus Trastuzumab As First-Line Therapy of Metastatic or Locally Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: The HERNATA Study ⬇️

artículo científico publicado el 13 de diciembre de 2010

Population pharmacokinetic modelling of unbound and total plasma concentrations of paclitaxel in cancer patients ⬇️

artículo científico publicado el 1 de mayo de 2003

Prognostic significance of stromal platelet-derived growth factor beta-receptor expression in human breast cancer

artículo científico publicado en 2009

Proteomics profiling identify CAPS as a potential predictive marker of tamoxifen resistance in estrogen receptor positive breast cancer

artículo científico publicado en 2015

Reducing the global breast cancer burden: the importance of patterns of care research

artículo científico publicado en 2005

Sequencing of breast cancer stem cell populations indicates a dynamic conversion between differentiation states in vivo

artículo científico publicado en 2014

Sequencing-based breast cancer diagnostics as an alternative to routine biomarkers

artículo científico publicado en 2016

Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series

artículo científico publicado en 2007

TP53 status for prediction of sensitivity to taxane versus non-taxane neoadjuvant chemotherapy in breast cancer (EORTC 10994/BIG 1-00): a randomised phase 3 trial

artículo científico publicado en 2011

The European Medicines Agency Review of Pertuzumab for the treatment of adult patients with HER2-positive metastatic or locally recurrent unresectable breast cancer: summary of the scientific assessment of the committee for medicinal products for hu

artículo científico publicado en 2014

The European Medicines Agency approval of axitinib (Inlyta) for the treatment of advanced renal cell carcinoma after failure of prior treatment with sunitinib or a cytokine: summary of the scientific assessment of the committee for medicinal product

artículo científico publicado en 2015

The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer

artículo científico publicado en 2006

The cost-effectiveness of routine postoperative radiotherapy after sector resection and axillary dissection for breast cancer stage I. Results from a randomized trial ⬇️

artículo científico publicado el 1 de agosto de 1997

The dyslexia candidate gene DYX1C1 is a potential marker of poor survival in breast cancer

artículo científico publicado en 2012

The risk of amenorrhoea after adjuvant chemotherapy for early stage breast cancer is related to inter-individual variations in chemotherapy-induced leukocyte nadir in young patients: data from the randomised SBG 2000-1 study

artículo científico publicado en 2009

Transcriptional consequences of genomic structural aberrations in breast cancer

artículo científico publicado en 2011

Vaccination with a plasmid DNA encoding HER-2/neu together with low doses of GM-CSF and IL-2 in patients with metastatic breast carcinoma: a pilot clinical trial

artículo científico publicado en 2010

Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer

artículo científico publicado en 2006

Validation of a novel procedure for quantification of the formation of phosphoramide mustard by individuals treated with cyclophosphamide.

artículo científico publicado en 2014

Validation of a radiosensitivity molecular signature in breast cancer.

scientific article published on 25 July 2012

Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial

artículo científico publicado en 2007

p53 Status predicts survival in breast cancer patients treated with or without postoperative radiotherapy: a novel hypothesis based on clinical findings ⬇️

artículo científico publicado el 1 de noviembre de 1995

Lista de obras de

A Phase I study of CHS 828 in patients with solid tumor malignancy

A catalyst for change: the European cancer Patient's Bill of Rights

A retrospective study of SBRT of metastases in patients with primary sarcoma

A simple method for assigning genomic grade to individual breast tumours

Adjuvant chemotherapy for breast cancer--"one fits all"?

Age-specific trends of survival in metastatic breast cancer: 26 years longitudinal data from a population-based cancer registry in Stockholm, Sweden

An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival

An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer

An iron regulatory gene signature predicts outcome in breast cancer.

Best use of adjuvant systemic therapies II, chemotherapy aspects: dose of chemotherapy-cytotoxicity, duration and responsiveness

Breast cancer associated with primary hyperparathyroidism: a nested case control study

Breast tumour stroma is a prognostic indicator and target for therapy

Characterisation of the G1/S cell cycle checkpoint defect in lung carcinoma cells with different intrinsic radiosensitivities

Clinical instability of breast cancer markers is reflected in long-term in vitro estrogen deprivation studies

Comprehensive long-span paired-end-tag mapping reveals characteristic patterns of structural variations in epithelial cancer genomes

Contrasting breast cancer molecular subtypes across serial tumor progression stages: biological and prognostic implications

Correlation test to assess low-level processing of high-density oligonucleotide microarray data

Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade

Dose intense, dose dense and tailored dose adjuvant chemotherapy for early breast cancer: an evolution of concepts

ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016

Erythropoietin therapy and cancer related anaemia: updated Swedish recommendations

Expression of Nestin associates with BRCA1 mutations, a basal-like phenotype and aggressive breast cancer

Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts

Great risk of future problems for Swedish cancer care

Growth-inhibitory and tumor- suppressive functions of p53 depend on its repression of CD44 expression

High expression of stromal PDGFRβ is associated with reduced benefit of tamoxifen in breast cancer

High-dose chemotherapy with autologous stem-cell support as adjuvant therapy in breast cancer: overview of 15 randomized trials.

Hormone-replacement therapy influences gene expression profiles and is associated with breast-cancer prognosis: a cohort study

How to treat male breast cancer

Immunohistochemistry compared to cytosol assays for determination of estrogen receptor and prediction of the long-term effect of adjuvant tamoxifen ⬇️

Inactivation of FBXW7/hCDC4-β expression by promoter hypermethylation is associated with favorable prognosis in primary breast cancer

Increased radioresistance of an in vitro transformed human small cell lung cancer cell line ⬇️

Inhibitory effects of estrogen receptor beta on specific hormone-responsive gene expression and association with disease outcome in primary breast cancer

Interactions between immunity, proliferation and molecular subtype in breast cancer prognosis

Interventional Techniques for Bone and Musculoskeletal Soft Tissue Tumors: Current Practices and Future Directions - Part I. Ablation

Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients

Long-term outcome in young women with breast cancer: a population-based study

MICADo - Looking for Mutations in Targeted PacBio Cancer Data: An Alignment-Free Method

Multidisciplinary meeting on male breast cancer: summary and research recommendations

Phase III Randomized Study Comparing Docetaxel Plus Trastuzumab With Vinorelbine Plus Trastuzumab As First-Line Therapy of Metastatic or Locally Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: The HERNATA Study ⬇️

Population pharmacokinetic modelling of unbound and total plasma concentrations of paclitaxel in cancer patients ⬇️

Prognostic significance of stromal platelet-derived growth factor beta-receptor expression in human breast cancer

Proteomics profiling identify CAPS as a potential predictive marker of tamoxifen resistance in estrogen receptor positive breast cancer

Reducing the global breast cancer burden: the importance of patterns of care research

Sequencing of breast cancer stem cell populations indicates a dynamic conversion between differentiation states in vivo

Sequencing-based breast cancer diagnostics as an alternative to routine biomarkers

Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series

TP53 status for prediction of sensitivity to taxane versus non-taxane neoadjuvant chemotherapy in breast cancer (EORTC 10994/BIG 1-00): a randomised phase 3 trial

The European Medicines Agency Review of Pertuzumab for the treatment of adult patients with HER2-positive metastatic or locally recurrent unresectable breast cancer: summary of the scientific assessment of the committee for medicinal products for hu

The European Medicines Agency approval of axitinib (Inlyta) for the treatment of advanced renal cell carcinoma after failure of prior treatment with sunitinib or a cytokine: summary of the scientific assessment of the committee for medicinal product

The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer

The cost-effectiveness of routine postoperative radiotherapy after sector resection and axillary dissection for breast cancer stage I. Results from a randomized trial ⬇️

The dyslexia candidate gene DYX1C1 is a potential marker of poor survival in breast cancer

The risk of amenorrhoea after adjuvant chemotherapy for early stage breast cancer is related to inter-individual variations in chemotherapy-induced leukocyte nadir in young patients: data from the randomised SBG 2000-1 study

Transcriptional consequences of genomic structural aberrations in breast cancer

Vaccination with a plasmid DNA encoding HER-2/neu together with low doses of GM-CSF and IL-2 in patients with metastatic breast carcinoma: a pilot clinical trial

Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer

Validation of a novel procedure for quantification of the formation of phosphoramide mustard by individuals treated with cyclophosphamide.

Validation of a radiosensitivity molecular signature in breast cancer.

Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial

p53 Status predicts survival in breast cancer patients treated with or without postoperative radiotherapy: a novel hypothesis based on clinical findings ⬇️